Abstract
• Background: The etiology and pathogenesis of keratoconus remain unclear, and therefore we decided to study the distribution of different isoforms of tenascin (Tn) and fibronectin (Fn) in normal human corneas and in those obtained from penetrating keratoplasty for keratoconus and corneal scarring. • Methods: Frozen sections of human cornea and conjunctiva were stained by immunohistochemical methods with a panel of monoclonal antibodies (MAbs) against different isoforms of Tn and Fn. • Results: In the normal human eye, Tn was found in the limbal and conjunctival basement membrane region, in the conjunctival blood vessels and at the junction of the cornea and sclera, but no immunoreaction was seen in the normal cornea. In the corneas from the keratoconus patients, a clear immunoreaction for Tn was seen in the defects of Bowman's membrane as well as in the distorted stroma beneath the defects. In some of the keratoconus corneas, basement membrane adjacent to the defects also showed reactivity for Tn, and in clinically and histologically scarred keratoconus corneas the scars expressed Tn. In the scarred corneas, only blood vessels in the posterior portion of the cornea showed immunoreactivity for Tn, while no Tn was noted in the scar area or in Bowman's membrane. No major differencies were noticed in the reactivity of different MAbs against Tn isoforms. Fn, extradomain A Fn (EDA-Fn) and oncofetal Fn (onc-Fn) were found in the basement membrane of the central cornea of the normal eye. In keratoconus corneas, the defects and clinical and histological scars bound MAbs against Fn, EDA-Fn and onc-Fn, but in the scarred corneas no enhancement in the expression of Fns was noted. Extradomain B cellular Fn (EDB-Fn) was not expressed in any of the eyes studied. • Conclusions: The results suggest that the anterior portion of the cornea is involved in the pathogenesis of keratoconus. Furthermore, it seems that the expression of Tn and Fns in the clinically scarred keratoconus corneas is due to a process in which both repairing and scar-forming mechanisms operate at the same time. However, the origin of the defects in Bowman's membrane seen in keratoconus still remains unclear. They may be minor scars due to the disease or primary defects in the process leading to keratoconus.
Similar content being viewed by others
References
Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L (1993) Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett 332: 39–43
Barraquer RI, Barraquer J (1994) Corneal dystrophies and keratoconus. Curr Opin Ophthalmol 5:53–67
Borsi L, Carnemolla B, Nicolo G, Spina B, Tanara G, Zardi L (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 52:688–692
Bron AJ (1988) Keratoconus. Cornea 7:163–169
Cai X, Foster CS, Liu JJ, Kupferman AE, Filipec M, Colvin RB, Lee SJ (1993) Alternatively spliced fibronectin molecules in the wounded cornea: analysis by PCR. Invest Ophthalmol Vis Sci 34: 3585–3592
Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, Natali PGTI (1989) A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol 108: 1139–1148
Chiquet-Ehrismann R, Matsuoka Y, Hofer U, Spring J, Bernasconi C, Chiquet M (1991) Tenascin variants differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul 2:927–938
Erickson HP (1993) Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 5: 869–876
Fukamauchi F, Mataga N, Wang Y-J, Sato S, Yoshiki A, Kusakabe M (1996) Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Biochem Biophys Res Commun 221: 151–156
Gromacki SJ, Barr IT (1994) Central and peripheral thickness in keratoconus and normal patient group. Optom Vis Sci 71:437–441
Kenney MC, Chwa M, Escobar M, Brown D (1989) Altered gelatinolytic activity by keratoconus corneal cells. Biochem Biophys Res Commun 161:353–357
Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I (1991) Tenascin in normal, reactive, hyperplastic and neoplastic tissues. Hum Pathol 22: 636–643
Latvala T, Tervo K, Mustonen R, Tervo T (1995) Expression of cellular fibronectin and tenascin in the rabbit cornea after excimer laser photorefractive keratectomy: a 12 month study. Br J Ophthalmol 79: 65–69
Lightner VA, Erickson HP (1990) Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci 95: 263–277
Linnala A, von Koskull H, Virtanen I (1994) Isoforms of cellular fibronectin and tenascin in amniotic fluid. FEBS Lett 337:167–170
Ljubimov A, Burgeson RE, Butkowski RJ, Couchman JR, Wu RR, Ninomiya Y, Sado Y, Maguen E, Nesburn AB, Kenney C (1996) Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 37: 997–1007
Mackie EJ (1994) Tenascin in connective tissue development and pathogenesis. Perspect Dev Neurobiol 2: 125–132
Mackie EJ, Halfter W, Liverani D (1988) Induction of tenascin in healing wounds. J Cell Biol 107:2757–2767
Matsuura H, Hakomori STI (1985) The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 82:6517–6521
Millin JA, Golub BM, Foster CS (1986) Human basement membrane components of keratoconus and normal corneas. Invest Ophthalmol Vis Sci 27:604–607
Mitrovic N, Schachner M (1995) Detection of tenascin-A in the nervous system of the tenascin-C mutant mouse. J Neurosci Res 42:710–717
Newsome DA, Foidart J-M, Hassel JR, Krachmer JH, Rodriques MM, Katz SI (1981) Detection of specific collagen types in normal and keratoconus corneas. Invest Ophthalmol Vis Sci 20:738–750
Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S (1992) Mice develop normally without tenascin. Genes Dev 6:1821–1831
Sawaguchi S, Yue BYJT, Chang I, Sugar J, Robin J (1991) Proteoglycan molecules in keratoconus. Invest Ophthalmol Vis Sci 32:1846–1853
Sawaguchi S, Twining SS, Yue BYJT, Chang SHL, Zhou X, Loushin G, Sugar J, Feder RS (1994) α2-Macroglobulin levels in normal human and keratoconus corneas. Invest Ophthalmol Vis Sci 35:4008–4014
Schermer A, Galvin S, Sun T-T (1986) Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 103:49–62
Schwarzbauer JE (1991) Alternative splicing of fibronectin: three variants, three functions. Bioessays 13: 527–533
Scroggs MW, Klintworth GK (1992) Normal eye and ocular adnexa. In: Sternberg SS (ed) Histology for pathologists. Raven Press, New York, p 906
Scroggs MW, Proia AD (1992) Histopathological variation in keratoconus. Cornea 11:553–559
Tervo K, Tervo T, van Setten G-B, Tarkkanen A, Virtanen I (1989) Demonstration of tenascin-like immunoreactivity in rabbit corneal wounds. Acta Ophthalmol 67: 347–350
Tervo T, van Setten G-B, Lehto I, Tervo K, Virtanen I (1990) Immunohistochemical demonstration of tenascin in the normal human limbus with special reference to trabeculectomy. Ophthalmic Res 22: 128–133
Tiitta O, Wahlström T, Paavonen J, Linnala A, Sharma S, Gould VE, Virtanen I (1992) Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Am J Pathol 141: 907–913
Tsubota K, Mashima Y, Murata H, Sato N, Ogata T (1995) Corneal epithelium in keratoconus. Cornea 14:77–83
Tuori A, Uusitalo H, Burgeson RE, Terttunen J, Virtanen I (1996) The immunohistochemical composition of the human corneal basement membrane. Cornea 15:286–294
Vartio T, Laitinen L, Närvänen O, Cutolo M, Thornell L-E, Zardi L, Virtanen I (1987) Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88:419–430
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tuori, A., Virtanen, I., Aine, E. et al. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefe's Arch Clin Exp Ophthalmol 235, 222–229 (1997). https://doi.org/10.1007/BF00941763
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00941763